Zoster Postherpetic Pruritus

What is Zoster Postherpetic Pruritus?

Postherpetic pruritus (PHP) is an itchy, often intense sensation that persists after an episode of herpes‑zoster (shingles). The itch usually appears in the same dermatome (skin area) that was involved in the original shingles rash and can last weeks to months, sometimes even years, after the rash has healed. While most people think of post‑herpetic neuralgia (pain) as the main lingering problem, itch is actually the second most common chronic sequela of shingles (Mayo Clinic, 2023). PHP is thought to result from abnormal regrowth or dysfunction of the peripheral nerves that were damaged by the varicella‑zoster virus (VZV) during the acute infection.

Common Causes

Postherpetic pruritus is usually a direct consequence of shingles, but several other conditions can either trigger a shingles episode or mimic its itching pattern.

• Herpes Zoster (Shingles) – Reactivation of dormant VZV in sensory ganglia.
• Post‑herpetic Neuralgia (PHN) – Overlapping pain pathways can generate itch.
• Peripheral Neuropathy – Diabetes, chemotherapy, or HIV can sensitize the same dermatomes.
• Contact Dermatitis – Irritants applied to a healing shingles rash may provoke persistent itch.
• Dry Skin (Xerosis) – Common in older adults; worsens itching after shingles.
• Psychogenic Itch – Stress or anxiety can amplify sensations in a previously injured nerve.
• Secondary Bacterial Infection – Superinfection of the healing rash may leave lingering pruritus.
• Autoimmune Skin Disorders – Conditions such as lichen planus can develop in the same area.
• Medication‑induced Pruritus – Opioids, antibiotics, or antihypertensives may heighten itch.
• Age‑related Cutaneous Changes – Thinning epidermis in the elderly reduces barrier function.

Associated Symptoms

Patients with postherpetic pruritus often notice additional sensations that can help differentiate it from ordinary itching.

• Tingling or “pins‑and‑needles” feeling (paresthesia)
• Burning or stinging sensations
• Allodynia – pain from light touch, such as clothing
• Residual hyper‑pigmentation or hypopigmentation at the site
• Dry, scaly skin in the affected dermatome
• Occasional mild pain episodes that may precede or follow itching spikes

When to See a Doctor

Most cases of PHP are manageable with over‑the‑counter measures, but you should schedule a medical appointment if any of the following occur:

• Itch persists for more than 6 weeks after the shingles rash has healed.
• There is a sudden increase in intensity or the itch becomes painful.
• Signs of infection appear (redness, warmth, swelling, pus, or fever).
• It interferes with sleep, daily activities, or causes noticeable skin damage from scratching.
• You have a weakened immune system (e.g., HIV, chemotherapy, organ transplant).

Diagnosis

Diagnosis is primarily clinical, based on your medical history and a focused skin exam.

History taking

• Onset of shingles rash, its distribution, and treatment received.
• Timeline of itching relative to rash resolution.
• Previous episodes of PHN, neuropathy, or dermatologic conditions.

Physical Examination

• Visual inspection of the affected dermatome for residual erythema, scaling, or scarring.
• Neurologic assessment of sensation (light touch, pinprick, temperature).

Additional Tests (if needed)

• Skin scraping or culture to rule out bacterial/fungal superinfection.
• Blood glucose or HbA1c if diabetic neuropathy is suspected.
• Neurophysiological studies (nerve conduction, quantitative sensory testing) – reserved for atypical cases.

Treatment Options

Therapy focuses on breaking the itch‑pain cycle, restoring skin barrier function, and, when needed, targeting the underlying nerve dysfunction.

Topical Therapies

• Low‑potency corticosteroids (e.g., hydrocortisone 1%) – reduce residual inflammation.
• Topical calcineurin inhibitors (tacrolimus or pimecrolimus) – useful for sensitive skin.
• Creams with menthol or camphor – provide a cooling counter‑stimulus.
• Barrier ointments (petrolatum, dimethicone) – prevent transepidermal water loss.

Systemic Medications

• Antihistamines – first‑generation (diphenhydramine) for nighttime relief; second‑generation (cetirizine, loratadine) for daytime use.
• Gabapentin or Pregabalin – neuropathic agents that have proven benefit for both PHN and pruritus (NIH, 2022).
• Tricyclic antidepressants (amitriptyline low dose) – modulate central itch pathways.
• Selective serotonin‑norepinephrine reuptake inhibitors (SNRIs) – duloxetine may help when pain and itch co‑exist.
• Opioid‑antagonist agents – low‑dose naltrexone is emerging as an option for refractory itch.

Procedural Interventions

• Capsaicin 8% patch – applied by a health professional; depletes substance P and can reduce itch for weeks.
• Neuromodulation – peripheral nerve blocks or transcutaneous electrical nerve stimulation (TENS) for severe cases.
• Laser therapy – low‑level laser has shown modest itch reduction in pilot studies.

Home & Lifestyle Measures

• Cool compresses (10‑15 minutes) 3–4 times daily.
• Gentle, fragrance‑free moisturizers applied immediately after bathing.
• Avoid scratching – use soft gloves or cuticles during nighttime.
• Wear loose, breathable clothing (cotton) over the affected area.
• Maintain a regular sleep schedule; sleep deprivation worsens itch perception.
• Stress‑reduction techniques (mindfulness, yoga) – psychological stress amplifies neuronal itch signals.

Prevention Tips

While you cannot completely prevent reactivation of VZV, several strategies lower the risk of both shingles and subsequent postherpetic pruritus.

• Shingles vaccination – Recombinant zoster vaccine (Shingrix) is >90 % effective in adults ≥50 years (CDC, 2023).
• Maintain good glycemic control if you have diabetes.
• Stay up to date with routine immunizations (flu, pneumococcal) that support overall immune health.
• Avoid prolonged use of topical steroids on healed skin; they can thin the epidermis.
• Use gentle skin care products; fragrance‑free soaps and detergents reduce irritation.
• Promptly treat acute shingles with antiviral therapy (acyclovir, valacyclovir, or famciclovir) within 72 hours – early treatment reduces the incidence of PHN and PHP.

Emergency Warning Signs

References:
1. Mayo Clinic. “Shingles (herpes zoster).” 2023. Link.
2. Centers for Disease Control and Prevention. “Shingles Vaccination (Shingrix).” 2023. Link.
3. National Institutes of Health. “Gabapentin for Post‑herpetic Neuralgia and Itch.” 2022. Link.
4. World Health Organization. “Varicella‑zoster virus.” 2022. Link.
5. Cleveland Clinic. “Postherpetic Neuralgia and Itch.” 2023. Link.